Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:10 AM
Ignite Modification Date:
2025-12-25 @ 12:10 AM
NCT ID:
NCT00003958
Eligibility Criteria:
Inclusion Criteria:
* Histologically proven disease of any of the following types:
* Non metastatic alveolar rhabdomyosarcoma
* Stage I, II, or III; Clinical Group I, II, or III
* Stage II or III, Clinical Group III embryonal rhabdomyosarcoma
* Botryoid
* Spindle cell
* Under 10 years, stage IV, Clinical Group IV embryonal rhabdomyosarcoma
* Botryoid
* Spindle cell
* Undifferentiated sarcoma
* Stage I, II, or III; Clinical Group I, II, or III
* Ectomesenchymoma
* Stage I, II, or III; Clinical Group I, II, or III, with alveolar features
* Under 10 years, Stage IV, Clinical Group IV, with embryonal features
* No more than 6 weeks since initial surgical procedure (e.g., biopsy) giving the definitive diagnosis
* No parameningeal rhabdomyosarcoma with positive CSF cytology or multiple intracranial metastases
* Bilirubin no greater than 1.5 mg/dL
* Creatinine normal\* for age
* Not pregnant or nursing
* Fertile patients must use effective contraception
* No prior chemotherapy
* Prior steroids allowed
* No prior radiotherapy
* See Disease Characteristics
Healthy Volunteers:
False
Sex:
ALL
Maximum Age:
49 Years
Study:
NCT00003958
Study Brief:
Protocol Section:
NCT00003958